Amundi Reduces Stock Position in CME Group Inc. $CME

Amundi trimmed its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 24.1% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,574,892 shares of the financial services provider's stock after selling 500,215 shares during the period. Amundi owned approximately 0.44% of CME Group worth $347,783,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. Empowered Funds LLC boosted its stake in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider's stock worth $2,660,000 after buying an additional 1,037 shares during the last quarter. Marshall Wace LLP lifted its holdings in CME Group by 103.1% in the second quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider's stock valued at $1,018,000 after acquiring an additional 121,707 shares during the period. Federated Hermes Inc. lifted its holdings in CME Group by 1,325.2% in the second quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider's stock valued at $6,497,000 after acquiring an additional 21,918 shares during the period. Nebula Research & Development LLC purchased a new position in CME Group in the second quarter worth about $992,000. Finally, The Manufacturers Life Insurance Company boosted its position in CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider's stock worth $79,344,000 after purchasing an additional 7,397 shares during the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Buying and Selling

In other CME Group news, Director William Shepard purchased 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The shares were bought at an average cost of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.30% of the company's stock.

CME Group Price Performance

CME opened at $281.29 on Tuesday. The stock has a market cap of $101.15 billion, a price-to-earnings ratio of 23.86, a price-to-earnings-growth ratio of 3.32 and a beta of 0.24. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm's fifty day moving average is $260.01 and its 200 day moving average is $278.05. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.CME Group's revenue for the quarter was up .8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.96 EPS. On average, sell-side analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group's dividend payout ratio (DPR) is 44.11%.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CME. Keefe, Bruyette & Woods raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price target for the company in a research report on Thursday, June 18th. Raymond James Financial reissued an "outperform" rating and issued a $320.00 price objective on shares of CME Group in a report on Thursday, July 2nd. Barclays cut their target price on shares of CME Group from $316.00 to $270.00 and set an "equal weight" rating for the company in a research report on Thursday, July 9th. Piper Sandler decreased their price target on shares of CME Group from $329.00 to $295.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 15th. Finally, Bank of America lifted their price target on shares of CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a research note on Thursday, July 23rd. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $289.75.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.